Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-09-23 4:20 pm Sale | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | JK BioPharma Solutions Inc | 0 0.000% | -2,618,012 (Position Closed) | View |
| 2021-11-10 2:17 pm Unchanged | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | JK BioPharma Solutions Inc | 2,618,012 9.800% | 0 (Unchanged) | View |
| 2020-01-10 09:51 am Purchase | 13D | NEUROBO PHARMACEUTICALS INC CO NRBO | JK BioPharma Solutions Inc | 2,618,012 16.700% | 2,618,012 (New Position) | View |